- Home
- LGVN vs GSIW Comparison
LGVN vs GSIW Comparison
Compare LGVN & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- GSIW
- Stock Information
- Founded
- LGVN 2014
- GSIW 2016
- Country
- LGVN United States
- GSIW Hong Kong
- Employees
- LGVN N/A
- GSIW N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- GSIW
- Sector
- LGVN Health Care
- GSIW
- Exchange
- LGVN Nasdaq
- GSIW Nasdaq
- Market Cap
- LGVN 23.4M
- GSIW 27.2M
- IPO Year
- LGVN 2021
- GSIW 2023
- Fundamental
- Price
- LGVN $1.30
- GSIW $1.53
- Analyst Decision
- LGVN Strong Buy
- GSIW
- Analyst Count
- LGVN 3
- GSIW 0
- Target Price
- LGVN $8.67
- GSIW N/A
- AVG Volume (30 Days)
- LGVN 138.8K
- GSIW 1.3M
- Earning Date
- LGVN 08-13-2025
- GSIW 12-31-2024
- Dividend Yield
- LGVN N/A
- GSIW N/A
- EPS Growth
- LGVN N/A
- GSIW N/A
- EPS
- LGVN N/A
- GSIW N/A
- Revenue
- LGVN $2,225,000.00
- GSIW $1,313,795.00
- Revenue This Year
- LGVN N/A
- GSIW N/A
- Revenue Next Year
- LGVN $51.48
- GSIW N/A
- P/E Ratio
- LGVN N/A
- GSIW N/A
- Revenue Growth
- LGVN 127.50
- GSIW N/A
- 52 Week Low
- LGVN $1.14
- GSIW $0.35
- 52 Week High
- LGVN $6.40
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- LGVN 50.13
- GSIW 77.76
- Support Level
- LGVN $1.15
- GSIW $1.39
- Resistance Level
- LGVN $1.32
- GSIW $1.58
- Average True Range (ATR)
- LGVN 0.09
- GSIW 0.17
- MACD
- LGVN 0.01
- GSIW 0.00
- Stochastic Oscillator
- LGVN 45.31
- GSIW 70.55
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.